Because BBBb precedes other detectable pathological changes, biomarkers such as platelet-derived growth factor receptor beta (PDGFRb), can serve for early detection prior to the onset of cognitive impairment facilitating early therapeutic interventions. Here, PDGFRB is linked to Cognitive impairment.